Terms to Know: Biofilm and Inflammation

DMCA.com Protection Status

Biofilm: Colonies of multiphenotype, free-floating bacteria that secrete a polysaccharide matrix that protects the bacteria from immune response and antibiotics.

Chronic wounds: Wounds that stall in the inflammation phase and fail to progress toward healing within 3 months are considered chronic or hard to heal.

Continuous inflammation: When wound healing becomes stalled in the inflammatory phase because of the presence of bacteria and their endotoxins, the wound is unable to move out of the inflammatory phase and into the repair phase.

Endotoxins: Substances that are present on the cell wall of gram-negative bacteria and cause an inflammatory response even in small amounts.

How much do you know about biofilm and inflammation? Take our 10-question quiz to find out! Click here.

Inflammation phase: The phase of wound healing following hemostasis. The inflammation phase is meant to control bleeding and prevent infection by sending repair cells to the wound site to remove debris and bacteria. This process may cause swelling, heat, pain, and redness in the wound area. This is the phase of wound healing where stalling happens, causing chronic or hard-to-heal wounds.

Microbiome: The community of organisms that live on the surface of the skin, such as bacteria, viruses, arthropods, and others.

Polysaccharide matrix: A substance secreted by biofilms that is made up of proteins, poly saccharides, and extracellular DNA and that provides protection from immune responses and antibiotics.

Proinflammatory cytokine: An immunoregulatory cytokine that favors inflammation. The net effect of an inflammatory response is determined by the balance between proinflammatory and anti-inflammatory cytokines.

Senescent cells: Cells that appear during late-stage healing and that release a continual cascade of inflammatory cytokines, chemokines, growth factors, and proteases. The presence of these cells may prolong the inflammatory period.

TIMERS: A framework for wound bed preparation to help resolve stalling factors in wound healing. It includes tissue management, inflammation, moisture balance, edge or epithelial advancement, repair or regeneration, and social factors.

August is Biofilm and Inflammation Month

The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, HMP Global, its affiliates, or subsidiary companies.

Recommended for You

  • December 31st, 2020

    Biofilms are found in the majority of chronic wounds and pose a critical health threat, causing nearly 80% of refractory nosocomial infections. They also have a damaging virulence mechanism, which induces resistance to antimicrobials and evasion from the host’s immune system. Over 90% of chronic...

  • March 31st, 2021

    Wound healing is often accompanied by bacterial infection. Many clinicians use antibiotics to treat wound infections. However, the overreliance on antibiotics is becoming an increasing concern for many global health organizations because it contributes to widespread antibiotic resistance....

  • January 24th, 2020

    By the WoundSource Editors

    The venous leg ulcer (VLU) is the most common type of chronic leg wound, and it can be challenging to manage. VLUs account for up to 90% of all chronic leg ulcers. Proper diagnosis and treatment planning are key to wound healing outcomes. This fact is...

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.